Skip to main content

Table 6 Volunteer typical daily dietary intake whilst consuming the placebo and treatment bread products

From: A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers

 

Calories

Protein

Fat

Carbohydrate

Fibre

Non starch polysaccharides

Iron

(kcal)

(g)

(g)

(g)

(g)

(g)

(mg)

placebo

1796.0

68.1

53.8

227.5

19.8

14.9

12.9

treatment

±726.1

±31.2

±25.2

±110.5

±7.9

±6.0

±8.5

AXOS

1900.3

73.6

64.1

227.2

18.9

14.4

11.2

treatment

±767.5

±53.0

±27.4

±127.3

±5.7

±4.3

±3.9

  1. (Average consumption from 4 consecutive days).